| Primary |
| Lymphoma |
55.6% |
| Nausea |
22.2% |
| Chronic Lymphocytic Leukaemia |
11.1% |
| Epilepsy |
11.1% |
|
|
| Secondary |
| Vomiting |
13.5% |
| Product Used For Unknown Indication |
12.4% |
| Drug Use For Unknown Indication |
10.5% |
| General Anaesthesia |
10.3% |
| Nausea |
8.8% |
| Antiemetic Supportive Care |
6.0% |
| Lymphoma |
5.8% |
| Pain |
4.9% |
| Arthralgia |
3.0% |
| Depression |
3.0% |
| Ill-defined Disorder |
3.0% |
| Neoplasm Malignant |
2.6% |
| Analgesic Therapy |
2.4% |
| Crohn's Disease |
2.4% |
| Induced Labour |
2.1% |
| Premature Labour |
2.1% |
| Headache |
1.9% |
| Productive Cough |
1.9% |
| Schizophrenia, Paranoid Type |
1.9% |
| Constipation |
1.7% |
|
| Vomiting |
15.9% |
| Angioedema |
11.4% |
| Tachycardia |
9.1% |
| Vision Blurred |
8.0% |
| Nausea |
6.8% |
| Confusional State |
4.5% |
| Intra-uterine Death |
4.5% |
| Necrotising Enterocolitis Neonatal |
4.5% |
| Weight Decreased |
4.5% |
| Drug Ineffective |
3.4% |
| Drug Interaction |
3.4% |
| Liver Function Test Abnormal |
3.4% |
| Pneumonia |
3.4% |
| Visual Impairment |
3.4% |
| Akathisia |
2.3% |
| Anorectal Disorder |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Haemorrhage |
2.3% |
| Headache |
2.3% |
| Irritable Bowel Syndrome |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Drug Use For Unknown Indication |
13.4% |
| Nausea |
9.6% |
| Pain |
7.8% |
| Prophylaxis Of Nausea And Vomiting |
4.5% |
| Prophylaxis |
4.3% |
| Acute Myeloid Leukaemia |
3.5% |
| Hypertension |
2.9% |
| Analgesic Therapy |
2.8% |
| Constipation |
2.7% |
| Vomiting |
2.6% |
| Breast Cancer |
2.1% |
| Infection |
1.8% |
| Antiemetic Supportive Care |
1.7% |
| Depression |
1.6% |
| Diarrhoea |
1.5% |
| Non-small Cell Lung Cancer |
1.2% |
| Chemotherapy |
1.2% |
| Alcohol Withdrawal Syndrome |
1.2% |
| Antifungal Prophylaxis |
1.1% |
|
| Vomiting |
24.5% |
| Renal Impairment |
8.5% |
| Thrombocytopenia |
5.3% |
| Renal Failure |
4.7% |
| Tachycardia |
4.4% |
| Neutropenic Sepsis |
4.2% |
| Platelet Count Increased |
4.2% |
| Pyrexia |
4.2% |
| Nausea |
3.8% |
| Neutropenia |
3.8% |
| Renal Failure Acute |
3.8% |
| Weight Decreased |
3.8% |
| Dyspnoea |
3.6% |
| Morbid Thoughts |
3.2% |
| Pulmonary Embolism |
3.2% |
| Tremor |
3.2% |
| Vena Cava Thrombosis |
3.2% |
| Delirium |
3.0% |
| Liver Function Test Abnormal |
2.7% |
| Psychotic Disorder |
2.7% |
|
| Interacting |
| Antiemetic Supportive Care |
23.7% |
| Lymphoma |
13.2% |
| Drug Use For Unknown Indication |
10.5% |
| Depression |
7.9% |
| Nausea |
7.9% |
| Analgesic Therapy |
5.3% |
| Ill-defined Disorder |
5.3% |
| Ovarian Cancer |
5.3% |
| Arthralgia |
2.6% |
| Chronic Lymphocytic Leukaemia |
2.6% |
| Crohn's Disease |
2.6% |
| Epilepsy |
2.6% |
| Headache |
2.6% |
| Hepatitis C |
2.6% |
| Pain |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
|
| Drug Interaction |
28.6% |
| Nausea |
28.6% |
| General Physical Health Deterioration |
14.3% |
| Headache |
14.3% |
| Serotonin Syndrome |
14.3% |
|
